HOCHDORF and Pharmalys Laboratories have launched Hochdorf Laboratories SA, a jointly owned company designed to accelerate global growth in the infant nutrition sector.

Led by HOCHDORF and backed by AS Equity Partners, the joint venture combines HOCHDORF’s Swiss manufacturing and production expertise with Pharmalys’ international brand portfolio and global market reach.

Also read: Rapid Multidisciplinary Care Saves 9-Month-Old in Critical Medical Emergency

The partnership integrates infant nutrition brands, intellectual property, and technical expertise into a single entity, aiming to improve operational efficiency, accelerate decision-making, and support long-term profitable growth.

“The formation of this joint venture represents a decisive step forward in our vision for Hochdorf. AS Equity Partners remains committed to providing the strategic and financial backing necessary to ensure this venture delivers long-term value for all stakeholders,” said Andreas Schulte, founder and managing partner at AS Equity Partners.

Click here to join our WhatsApp channel here

“By bridging Hochdorf’s industrial excellence with Pharmalys’ commercial strength, we are creating a high-performance platform poised for international expansion,” said Amir Mechria, chairman of the board at Pharmalys Laboratories.

The new company is expected to create a stronger platform for innovation and global expansion in the infant nutrition market.